- Pancreas Cancer Academy 2022
- Breast Cancer Webinar
- NSCLC 2022 Webinar
- CECOG Immuno-Oncology Symposium
- Pancreatic Cancer
- Colon Cancer
- Post ESMO Webinar
- Post SABCS Webinar
- Videos
- Events
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Expert Discussion on PRODIGE 24 Data on FOLFIRINOX vs. Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
373 views
March 31, 2021
Comments 0
Login to view comments.
Click here to Login
Pancreatic Cancer